Working together to help with the cost of cancer - Citizens Advice

Here we report that under basal conditions, ERalpha Ser294 is the target of Pin1. We demonstrated by GST pulldown and coimmunoprecipitation assays on MCF7 cell extracts that Pin1

We found out that there are confident differences between participants with strong and weak types of nervous system by HBR indicator before fulfillment of exercise, analogous

Since oxaliplatin and nedaplatin have been effective against cisplatin-resistant ovarian cancer in clinical trials, and targeting STAT3 may reverse drug resistance, we

With this paper, we intend to verify in what extent does Information and Communication Technologies (ICT) help patients with chronic diseases to promote their self-care

With this on mind and because erlotinib was the last new drug introduced in Portugal for the second and third-line treatment of advanced or metastatic NSCLC, a cost-minimization

Therefore, we designed custom high-density oligonucleotide microarrays (Nim- bleGen Inc.) to capture a total of approximately 1.7 Mb target regions comprising the genomic regions of

We have demonstrated that inhibition of AKT not only increases PRB protein levels, but that it acts with progestin to decrease cell viability, increase apoptosis, and cause a

vascular parameters of the axillary and brachial vessels in women who underwent treatment for breast cancer. We subdivided these assessments according to the